Yazar "Yildiran, A." için listeleme
-
A child diagnosed as IL-12R deficient with disseminated BCG infection
Yildiran, A.; Ak, E.; Picard, C.; Sancak, R. (Wiley-Blackwell, 2010)… -
A comparison of B cell subsets in primary immune deficiencies that progress with antibody deficiency and age-matched healthy children
Celiksoy, M. H.; Yildiran, A. (Elsevier Espana Slu, 2016)Background: The objective of this study was to examine the B lymphocyte subsets in primary immunodeficiency that progress with antibody deficiency. Methods: The patients' naive, memory, class-switched memory and non-switched ... -
Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups
Celiksoy, M. H.; Topal, E.; Yildiran, A. (Elsevier Doyma Sl, 2015)Background: Ataxia telangiectasia (A-T) is a genetic disorder caused by the homozygous mutation of the A-T mutated gene. It is frequently associated with variable degrees of cellular and humoral immunodeficiency. However, ... -
Complementary and alternative medicine in children with allergic diseases
Guner, S.; Kilic, M.; Ozturk, F.; Yildiran, A.; Sancak, R. (Wiley-Blackwell, 2011)… -
Is parturition-timing machinery related to the number of inhibitor CD94/NKG2A positive uterine natural killer cells?
Mazi, E.; Altunkaynak, Z.; Aydin, I.; Kocak, I.; Guven, D.; Turkmen, A. P.; Yildiran, A. (Springer Heidelberg, 2016)Prematurity is the most common cause of infant mortality and morbidity. To prevent this, the timing of parturition and its mechanisms should be understood. It is likely that inhibitor CD94/NKG2A positive decidual natural ... -
The prevalence of the food allergy in nursery and kindergarten students
Barlik, F.; Guner, S.; Kilic, M.; Barlik, M.; Ozturk, F.; Yildiran, A.; Sancak, R. (Wiley-Blackwell, 2011)… -
The rote of active B cells in allergen immunotherapy
Celiksoy, M. H.; Sancak, R.; Yildiran, A. (Elsevier Espana Slu, 2017)Background: The purpose of this study is to examine the changes in B lymphocyte subsets in patients receiving allergen immunotherapy. Methods: B lymphocyte subsets of patients before immunotherapy and one year after ... -
Severe Combined Immunodeficiency: Clinical, Immunological Features and Outcome in 50 Cases
Dogu, F.; Cipe, F.; Aytekin, C.; Karatas, D.; Kendirli, T.; Yildiran, A.; Ikinciogullari, A. (Springer/Plenum Publishers, 2012)…
